HANNA FERNANDEZ: Open Payments
NPI 1881293371 · GULFPORT, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$929 in 38 payments from 8 companies in 2025. Trend: 2023 $353 · 2024 $741 · 2025 $929
Food & beverage: $831Education: $98
| Company | Payments | Amount |
|---|---|---|
| Tarsus Pharmaceuticals, Inc. | 6 | $205 |
| ABBVIE INC. | 9 | $187 |
| Amgen Inc. | 10 | $171 |
| Mallinckrodt Hospital Products Inc. | 3 | $147 |
| ANI Pharmaceuticals, Inc. | 5 | $88 |
| Dompe US, Inc. | 3 | $81 |
| Rayner Intraocular Lenses Limited | 1 | $35 |
| Oyster Point Pharma, Inc. | 1 | $15 |
Products named: XDEMVY, TEPEZZA, DURYSTA, ACTHAR, OXERVATE, ILUVIEN, XEN GLAUCOMA TREATMENT SYSTEM, Omidria.
Industry payments across MS — which companies pay providers there.
